| Product Name | Afatinib-d6 |
| Product Code | DA-A082-11 |
| Chemical name | Afatinib-d6 |
| Synonyms | (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide-d6; BIBW 2992-d6; |
| Impurity | NA |
| CAS Number | 1313874-96-2 |
| Alternate CAS # | NA |
| Molecular form | C24H19D6ClFN5O3 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 491.98 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | stable isotopes |
| Boiling Point | NA |
| Applications | Afatinib-d6 is the d6 labelled analogue of Afatinib which is an aminocrotonylamino-substituted quinazoline derivative used for treating cancer and diseases of the respiratory tract, lungs, gastrointestinal tract, bile duct, and gallbladder. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
| NA |
